APA (7th ed.) Citation

Park, S. J., Kim, J., Kim, H. S., Lee, J., Chang, H. K., Lee, K. H., . . . Shim, S. (2020). Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: A Korean multicenter retrospective cohort study. Journal of gynecologic oncology, 31(2), e15-13. https://doi.org/10.3802/jgo.2020.31.e15

Chicago Style (17th ed.) Citation

Park, Soo Jin, et al. "Real World Effectiveness and Safety of Pegylated Liposomal Doxorubicin in Platinum-sensitive Recurrent Ovarian, Fallopian, or Primary Peritoneal Cancer: A Korean Multicenter Retrospective Cohort Study." Journal of Gynecologic Oncology 31, no. 2 (2020): e15-13. https://doi.org/10.3802/jgo.2020.31.e15.

MLA (9th ed.) Citation

Park, Soo Jin, et al. "Real World Effectiveness and Safety of Pegylated Liposomal Doxorubicin in Platinum-sensitive Recurrent Ovarian, Fallopian, or Primary Peritoneal Cancer: A Korean Multicenter Retrospective Cohort Study." Journal of Gynecologic Oncology, vol. 31, no. 2, 2020, pp. e15-13, https://doi.org/10.3802/jgo.2020.31.e15.